The Q-system is a binary expression system that works well across species. Here we report the 10 development of a split-QF system that drives strong expression, is repressible by QS and inducible by 11 quinic acid. The split-QF system is fully compatible with existing split-GAL4 and split-LexA lines for 12
We reasoned that, since the QF2/QF2 w (a weaker version of QF2, with a mutated C-terminal 4 ) 23 transactivators of the Q-system are generally stronger than GAL4 4 , the split-QF system may function 24 well in Drosophila by coupling QFDBD and QFAD 9 . This would allow the system to remain both 25 repressible by QS and inducible by quinic acid (QA), in the same manner as the original Q-system. 26 We have also previously developed chimeric GAL4QF and LexAQF transactivators 4 , which indicated 27 that QFAD and QF2 w AD are likely to function with GAL4DBD and LexADBD domains when brought 28 together by leucine zippers. 29
To make the split-QF system compatible with existing split-GAL4 lines, we used the same leucine 30 zippers 10 . We attached Zip-to QFDBD and Zip+ to QFAD and QF2 w AD, defining the domains as 31 previously reported 4 , and expressed these transgenes under control of the neuronal synaptobrevin 32
promoter nsyb (Fig 1a) . As expected, animals carrying nsyb-QFDBD(attp40), nsyb-QFAD(attp2) and 33
QUAS-mCD8-GFP had strong GFP expression throughout their nervous system (Fig 1B) . This 34 expression was repressible by tub-QS and inducible by QA (Supplementary Fig 1) . Similar, but 35 weaker expression was observed with nsyb-QFDBD and nsyb-QF2 w AD (Fig 1B) . Both split 36 transactivators appeared to have lower activity than the QF2 and QF2 w (Fig 1B) . 37
To compare QFAD and QF2 w AD to existing p65AD and GAL4AD, we generated nsyb-p65AD (attp2) 38 and nsyb-GAL4AD (attp2) flies, and expressed firefly luciferase pan-neuronally in larvae and adults 39 (Fig 1C,D, Supplementary Tables 1,2) . While relative expression levels varied between larvae (non-40 sexed) and male vs. female adults, QFAD was ~2 times (p<0.01) stronger than QF2 w AD, and ~2 times 41 (p<0.0001) weaker than p65AD. The GAL4AD was consistently weak. tub-QS provided strong 42 repression of all original and split QF variants. We quantified the effect of QA de-repression in larvae 43 only, because QA is effective only in sensory receptor neurons and the PI neurons in the adult brain 4 , 44
presumably due to the glial blood-brain barrier 11 . QA feeding to tub-QS, nsyb-QFDBD, nsyb-QFAD 45 (QF2 w AD) larvae, that otherwise had very low expression, resulted in restoration of expression to the 46 levels not significantly different from nsyb-QFDBD, nsyb-QFAD (QF2 w AD) larvae (p=0.87 and p=0.62, 47 respectively). These experiments demonstrate that the split-QF is fully functional, repressible and 48 inducible, due to the strong activity of the QFAD and QF2 w AD activation domains. 49
Next we asked whether QFAD and QF2 w AD may be effectively used together with existing GAL4DBD 50 lines, to provide an alternative to the currently used p65AD. Expression in larvae, driven by elav-51
GAL4DBD and nsyb-QF2/QF2 w AD, is strong, QS-repressible and QA-inducible (Fig 2A, top) . In adults 52 the expression was strong and repressible in neurons consistent with the predicted expression 53 pattern for each line, and QA-inducible in the olfactory and gustatory receptor neurons (Fig 2A,  54 bottom, Supplementary Fig 2) . To quantify the strength of expression, we used elav-GAL4DBD and 55
the AD variants to drive luciferase in larval CNS. Note: the elav-GAL4DBD, nsyb-p65AD combination 56 was lethal (Fig 2B, Supplementary Table 3 ). QFAD-induced expression was not significantly different 57 from QF2 w AD (p=0.16). In contrary to the experiments with split-QF ( Fig. 1C) , here QA resulted in 58 restoration of expression to ~20-35% of that of the un-repressed split transactivators (p<0.0001). To 59 quantify expression levels in the adult CNS, we used ChAT-GAL4DBD to target cholinergic neurons 60 and to avoid larval lethality, previously observed with elav-GAL4DBD, nsyb-p65AD (Fig 2C,  61 Supplementary Table 4 ). QFAD-driven expression was comparable with QF2 w AD (p>0.99) and ~4 62 times weaker than p65AD (p<0.0001). tub-QS provided strong repression, not different from DBD-63 only or AD-only controls (p>0.99). These experiments demonstrate that QFAD and QF2 w AD 64 activation domains may be used together with GAL4DBD lines to provide a repressible and inducible, 65 albeit weaker, alternative to p65AD. 66
The QFAD and QF2 w AD activation domains also work with split-LexA reagents in larval and adult CNS 67 (Fig 2D, Supplementary Figure 3) . Moreover, expression is both repressible and QA-inducible. 68
Although we did not quantify strength of expression by luciferase (due to the unavailability of a 69
LexAop-Luc reporter), it appears that QF2 w AD domain works as well, or better, than QFAD in these 70 experiments. 71
Next we asked how the QS repression compares with Killer-Zipper 12 that silences split-GAL4 72 expression by driving GAL4DBD-Zip+ construct with the LexA/LexAop system (Fig 3A, B The split-QF system may be effectively used for simultaneous expression of UAS and LexAop 79 transgenes: QF2 w AD, when combined with GAL4DBD and ZpLexADBD, drives simultaneous 80 expression of both UAS-RFP and LexAop-GFP (Fig 3C) . To test the usability of split-QF for advanced 81 intersectional experiments, we regulated expression of QS via the FLP-FRT system that, in turn, 82 controlled the split-transactivators. As expected, intersection of Chat-GAL4DBD, nsyb-QF2 w AD and 83
GH146-FLP resulted in strong labelling of cholinergic olfactory projection neurons (Fig 3D, left) . No 84 labelling was observed when Chat-GAL4DBD was replaced by glutamatergic driver VGlut-GAL4DBD 85
(not shown). Similarly, we observed expression throughout the brain and in the optic lobes in the 86 cholinergic, but not glutamatergic (not shown), neurons that are targeted by 20C11-FLP 13 (Fig 3D,  87 middle). Interestingly, intersection of VT009847-ZpLexADBD, nsyb-QFAD and 20C11-FLP resulted in 88 labelling only one SEZ neuron (Fig 3D, right) . These experiments demonstrate that split-QF can 89 effectively achieve simultaneous and intersectional expression, narrowing down expression patterns 90 of split-GAL4, split-LexA and FLP lines. 91
92
We applied the split-QF system to study physiology and behaviour in Drosophila. We performed 93
whole-cell patch-clamp recordings from aCC and RP2 motorneurons of third-instar larvae. Neuronal 94 depolarisation was evoked through activation of UAS-ChR2 14 expressed in all motoneurons by 95
VGlut-GAL4DBD, nsyb-QF2 w AD or, in controls, VGlut-GAL4 (Fig 3E, Supplementary Table 6 ). The 96 number of action potentials produced from VGlut-GAL4DBD, nsyb-QF2 w AD larvae (42 ± 6 per 500ms) 97
was not different from that in the GAL4 controls (51 ± 6, p=0.62). QS completely eliminated ChR2-98
induced depolarization in tub-QS,VGlut-GAL4DBD, nsyb-QF2 w AD larvae (Fig 3E) , while feeding larvae 99
of the same genotype with QA partially restored depolarization and action potential count (10 ± 5), 100 but significantly below the unrepressed levels of VGlut-GAL4DBD, nsyb-QF2 w AD larvae (p=0.0016). 101
These readouts of cellular activity are paralleled by behavioural phenotypes. We counted how many 102 times (in 2 mins) larvae of these 4 genotypes escaped a blue light area (Fig 3D, Supplementary Table  103 6). As expected, larvae containing the QS transgene escaped most readily (11 ± 1.8 escapes), while 104 feeding larvae with QA significantly reduced the number of escapes to 9.3 ± 1.3 (p=0.038), due to 105 the seizure-like neuronal activity, elicited by ChR2 activation. VGlut-GAL4DBD, nsyb-QF2 w AD were 106 also able to escape (5.9 ± 0.6), but significantly less than the QS larvae (p<0.0001). VGlut-GAL4 107 control larvae were unable to escape (0.2 ± 0.1). 108
We used the same assay to measure larval escape following activation of ChR2 driven pan-109 neuronally by split-QF (Fig 3G,Supplementary Table 7) . Abolished mobility was observed in larvae 110 that expressed ChR2 (0 ± 0 escapes in nsyb-QFDBD, nsyb-QFAD and nsyb-QFDBD, nsyb-QF2 w AD 111 larvae), and in larvae that expressed QS and fed with QA (0.3 ± 0.2 and 0.1 ± 0.1 escapes for QFAD 112 and QF2 w AD, respectively). By contrast, QS-expressing larvae not fed with QA readily escaped the 113 blue light area (7.4 ± 0.7 and 8.0 ± 0.8 escapes, respectively). 114
Finally, we assayed adult flies with pan-neuronal expression of shibire TS (Fig 3H, Supplementary  115 Table 8). When placed in 33°C, nsyb-QFDBD, nsyb-QFAD flies became gradually paralysed as 116 expected. The same effect was observed in nsyb-QFDBD, nsyb-QF2 w AD flies, but took longer to 117 develop, presumably due to the lower expression levels of shibire TS . When the expression of shibire TS 118 was suppressed by tub-QS, no paralysis was observed. 119
These experiments demonstrate that split-QF may be used with or without split-GAL4 to direct 120 expression of effectors in electrophysiological and behavioural assays. 121
In summary, we present a split-QF system that is applicable for advanced anatomical, behavioural 122 and physiological manipulations in Drosophila. This system is fully compatible and complementary 123
with the existing split-GAL4 and split-LexA lines and can greatly expand their use by making them 124 QS-repressible and QA-inducible. In addition, combinations of split-QF with split-GAL4 and split- where nsyb-QFDBD, nsyb-QFAD, QUAS-shi TS and nsyb-QFDBD, nsyb-QF2 w AD, QUAS-shi TS flies 229 performed significantly differently (t-test with Holm-Sidak correction for multiple comparisons). 230
Online methods 231

Molecular biology 232
Plasmids were constructed by standard procedures including enzyme digestions, PCR and 233 subcloning, using the In-Fusion HD Cloning System CE, Takara Bio Europe # 639636. Plasmid inserts 234
were verified by DNA sequencing. 235 nsyb-nls::QFAD::Zip+ construct 236 1) pattB-QF2-hsp70 plasmid (Addgene #46115) was digested with ZraI and EcoRI to remove 237
Kozak-QF2 sequence. 238
2) Kozak-nls sequence was PCR-amplified from pBPp65ADZpUw (Addgene #26234) with 239
primers ATC GAC AGC CGA ATT CAA CAT GGA TAA AGC GGA ATT A (forward) and ACG GTA 240 TCG ATA GAC GTC CAA TTC GAC CTT TCT CTT C (reverse). 241
3) The PCR product was cloned into the digested vector by InFusion cloning. 242
4) The cloning product was digested with ZraI 243 5) QFAD sequence was PCR-amplified from pattB-QF2-hsp70 plasmid (Addgene #46115) with 244
primers AAG GTC GAA TTG GAC GTC CGT CAG TTG GAG CTA A (forward) and ACG GTA TCG 245
ATA GAC AGA TCT CTG TTC GTA TGT ATT AAT GTC GGA GAA G (reverse) 246
6) The PCR product (5) was subcloned into (4) by InFusion cloning. 247 7) (6) was digested with BglII 248
8) The GGGGG-Zip+ sequence was PCR-amplified from pBPp65ADZpUw (Addgene #26234) with 249 primers ATA CGA ACA GAG ATC TGG AGG AGG TGG TGG AGG (forward) and ATC GAT AGA 250 CAG ATC GGC CGG CCT TAC TTG CCG CCG CC (reverse). 251
9) The PCR product (8) was subcloned into the digested vector (7) by InFusion cloning. 252 10) Product of (9) was digested with FseI and NotI to remove hsp70 terminator and to replace it 253 with SV40 terminator 254 11) SV40 terminator was PCR-amplfied from UAS-LUC-UAS-eYFP plasmid 15 with primers GGC 255 AAG TAA GGC CGG CCG ATC TTT GTG AAG GAA CCT TAC (forward) and CCT CGA GCC GCG 256 GCC GCG ATC CAG ACA TGA TAA GAT AC (reverse). 257
12) The PCR product (11) was subcloned into the vector (10) by InFusion cloning. 258 nsyb-nls::QF2 w AD::Zip+ construct 259 1) The nsyb-nls::QFAD::Zip+ construct was digested with BglII and ZraI to remove QFAD. 260
2) QF2 w AD sequence was PCR amplified from from pattb-QF2-hsp70 (Addgene #46115) with 261 primers AAG GTC GAA TTG GAC GTC CGT CAG TTG GAG CTC C (forward) and CAC CTC CTC 262 CAG ATC TTT CTT CTT TTT GGT ATG TAT TAA TGT CGG AGA AGT TAC ATC C (reverse) 263
3) The PCR product (2) was InFusino-cloned into (1). 264
nsyb-nls::p65AD::Zip+ construct 265
1) The nsyb-nls::QFAD::Zip+ construct was digested with FseI and ZraI to remove QFAD::Zip+ 266 sequence. 267
2) The p65AD::Zip+ sequence was PCR amplified from pBPp65ADZpUw (Addgene #26234) with 268 primers AAG GTC GAA TTG GAC GTC GGA TCC ACG CCG ATG (forward) and CTT CAC AAA GAT 269 CGG CCG GCC TTA CTT GCC GCC GCC (reverse). 270
3) The PCR product (3) was InFusion-subcloned into (1). 271 nsyb-nls::GAL4AD::Zip+ construct 272 1) The nsyb-nls::QFAD::Zip+ construct was digested with BglII and ZraI to remove QFAD. 273
2) The GAL4AD sequence was PCR amplified from pBPGAL4.2Uw-2 (Addgene #26227) with 274 primers AAG GTC GAA TTG GAC GTC GCC AAC TTC AAC CAG AGT GG (forward) and CAC CTC 275 CTC CAG ATC TCT CCT TCT TTG GGT TCG GTG (reverse). 276
3) The PCR product (3) was InFusion-subcloned into (1). 277 278 nsyb-Zip-::QFDBD construct 279 1) pattB-QF2-hsp70 plasmid (Addgene #46115) was digested with ZraI and EcoRI to remove 280
Kozak-QF2 sequence. 281
2) Kozak-Zip --GGGGGG sequence was PCR-amplified from pBPZpGAL4DBDUw (Addgene 282 #26233) with primers ATC GAC AGC CGA ATT CAA CAT GCT GGA GAT CCG C (forward) and 283
ACG GTA TCG ATA GAC GTC ACC TCC ACC TCC ACC TCC (reverse). 284
3) The PCR product (3) was InFusion-subcloned into (1). 285 4) (3) was digested with ZraI 286 5) QFDBD was PCR-amplified from pattB-QF2-hsp70 plasmid (Addgene #46115) with primers 287
GGA GGT GGA GGT GAC GTC ATG CCA CCC AAG CG (forward) and ACG GTA TCG ATA GAC 288
GGC CGG CCT TAG AGG AGG CGG GTA ATG C (reverse). 289
6) The PCR product (5) was InFusion-subcloned into (4). 290 7) (6) was digested with FseI and NotI to remove hsp70 terminator and to replace it with SV40 291 terminator 292 8) SV40 terminator was PCR-amplfied from UAS-LUC-UAS-eYFP plasmid 15 with primers CTC CTC 293
TAA GGC CGG CCG ATC TTT GTG AAG GAA CCT TAC (forward) and CCT CGA GCC GCG GCC 294 GCG ATC CAG ACA TGA TAA GAT AC (reverse). 295
9) The PCR product (8) was InFusion-subcloned into (7). 296 297
Transgenic flies (new and existing) 298
New transgenic lines were generated by inserting nsyb-QFDBD construct in attp40 (II) and all nsyb-299 AD constructs into attp2 (III). 300
Other Drosophila stocks, used in this paper, were acquired from the Bloomington Stock Centre 301 (indicated by # below) or were in personal stocks of the authors. 302 Dissection and immunostaining of adult brains was done as described previously 4 . Briefly, on day 1 316 brains of 5-7 d.o. adult flies were dissected in ice-cold PBS, fixed at RT for 20 mins in 4% PFA in 317 PBS+0.3% Triton (PBT), then washed in PBT at RT for 1.5-6h, blocked in 5% normal goat serum (NGS) 318
in PBT for 30 mins and placed in primary antibody mix at 4C for 3 nights on a shaker. On day 4, 319 brains were washed in PBT at RT for 5-6h and placed in secondary antibody mix for 2 nights at 4C 320 on a shaker. On day 6, brains were washed in PBT for 5-6h and left overnight in approx. 50μl of 321
Vectashield mounting solution without shaking. On day 7, brains were mounted in Vectashield on a 322 microscope slide. The primary antibody mix contained rabbit anti-GFP (Invitrogen #A11122, 1:100), 323 mouse nc82 (DSHB, 1:25) and 5% NGS in PBT. The secondary antibody mix contained Alexa Fluor 488 324 goat anti-rabbit (Invitrogen #A11034), Cy3 anti-mouse (Jackson Immunoresearch #115-165-062) and 325 5% NGS in PBT. 326
Images were acquired as z-stacks using a Leica SP8 upright confocal microscope equipped with HCX 327 IRAPO L25x/0.95W water-immersion objective (Leica, Germany, 506323), at 512 x 512 pixel 328 resolution with 1μm z steps. LAS X v3.5.2 software was used for image acquisition. Imaging settings 329
(laser intensity, gain, etc.) were kept identical for groups of images that were compared to one 330
another. Images were processed by taking maximum intensity projection, rotating and re-colouring 331 in FIJI. Images shown are representative of 3-5 stainings for every genotype. 332 333
Whole-animal imaging 334
Third-instar larvae were placed on a microscope slide and briefly put into a freezer to immobilize 335 them. Images were taken on a Leica MZ10F zoom fluorescent scope equipped with a Leica DFC 420C 336 camera, QImaging LED light source and LAS v.4 software. The white balance was adjusted 337 automatically by taking an image of a white sheet of paper before experimental images. Identical 338 settings were used to take images that are compared to each other. Images shown are 339 representative of 3-5 for every genotype. 340 341
Quinic acid feeding 342
For larval experiments, gravid females were allowed to lay eggs in vials containing standard fly 343 medium, supplemented with QA, and larvae remained in the vials until they reached wall-climbing 344 3 rd instar stage. For adult experiments, flies were raised on standard fly medium and were 345 transferred into vials with QA at 2-3 d.o., for 5 days, at which point they were dissected. To make QA 346 stock, 8 g of QA (Sigma #138622) was dissolved in 40 ml ddH 2 0 and adjusted to pH7 with 5M NaOH, 347
bringing the total stock volume to 50 ml. data point, presented on the graphs (Fig 1C-D, 2B-C, 3A-B 
Larval escape assays 407
Individual 3 rd instar larvae were assayed at RT (20-22C) in a 9cm petri dish that contained a thin layer 408 of 1% agarose to prevent desiccation. The petri dish was placed under the Leica MZ16F zoom 409 fluorescent microscope with Plan 1.0x lens, fluorescent light source and a GFP filter cube (λ470 nm). 410
Light intensity measured 9.87 mW/cm 2 when completely zoomed out. Zoom 5 was used for 411 experiments. Larvae were filmed using a uEye UI-233xSE-C camera with uEye Cockpit software, and 412
data was stored in *.avi format. Each larvae was allowed to crawl in the Petri dish for 2 mins, before 413 it was placed for 2 mins into a 113mm 2 area, illuminated by blue light. Wild-type larvae naturally 414 avoid bright blue light and crawl away, however, larvae with ChR2 expressed in motoneurons ( Fig  415  3F) or pan-neuronally (Fig 3G) are impaired in their ability to escape. A larva was returned into the 416 blue light area immediately after the larva had completely left the illuminated area. We counted the 417 number of escapes during a 2 min period. 7-15 larvae were assayed per genotype. The data is shown 418 as mean±SEM. The genotypes were compared with 1-way ANOVA with Sidak's multiple comparison 419 test. 420 421
Adult behavioural assay 422
Adult male and female 5-7d.o. flies were assayed in groups of 10 (N=4-5 groups per genotype) in 423 clean empty standard fly vials. Flies were placed in a cooled incubator, set to 33C, and video-424 recorded at 5 fps using a uEye camera UI-233xSE-C, controlled by uEye Cockpit software. The data 425 was stored in *.avi format. The number of flies on the bottom of each vial was manually counted at 426 30s intervals. The data is shown as mean±SEM, and was analysed with multiple t-tests with Holm-427
Sidak correction. 428
429 Supplementary Table 1 
. Quantification of expression strength of split-QF reagents in larvae 448
Larval genotype
Relative luciferase activity, mean±SEM N nsyb-QFDBD, nsyb-QFAD, QUAS-Luc 341 ± 17 10 tub-QS,nsyb-QFDBD, nsyb-QFAD, QUAS-Luc 15 ± 1 8 tub-QS,nsyb-QFDBD, nsyb-QFAD, QUAS-Luc + QA 266 ± 61 5 nsyb-QFDBD, nsyb-QF2 w AD, QUAS-Luc 143 ± 33 10 tub-QS,nsyb-QFDBD, nsyb-QF2 w AD, QUAS-Luc 10 ± 1 10 tub-QS,nsyb-QFDBD, nsyb-QF2 w AD, QUAS-Luc + QA 221 ± 29 10 nsyb-QFDBD, nsyb-p65AD, QUAS-Luc 654 ± 42 6 nsyb-QFDBD, nsyb-GAL4AD, QUAS-Luc 24 ± 4 5 nsyb-QF2, QUAS-Luc 767 ± 91 5 tub-QS,nsyb-QF2, QUAS-Luc 20 ± 2 5 tub-QS,nsyb-QF2, QUAS-Luc + QA 376 ± 75 6 nsyb-QF2 w , QUAS-Luc 431 ± 55 10 tub-QS,nsyb-QF2 w , QUAS-Luc 11 ± 1 10 tub-QS,nsyb-QF2 w , QUAS-Luc + QA 258 ± 33 10 449
